Cofactor will automatically discover the description of this topic and display it here.


Psoriatic arthritis is a heterogeneous systemic inflammatory disease with hallmark manifestations in joints and skin, affecting more than 50 million people worldwide. In psoriatic arthritis, the immune system creates inflammation that can lead to pain, fatigue and stiffness in the joints.

OSE Immunotherapeutics hopes to deploy the partnership on fusion protein technology called BiCKl. This technology is being developed to tackle cancers resistant to immune checkpoint inhibitor therapies, which prevent cancer from hiding from the immune system.

See also

See also: